Rob Winn Appointed Director of NCI-Designated Fox Chase Cancer Center
oncodaily - Fox Chase Cancer Center shared a post on LinkedIn: “Temple Health – Temple University Health System today announced the appointment of Dr. Rob Winn, MD, as the next Cancer Center […]
AI Summary: Rob Winn has been appointed director of the NCI‑designated Fox Chase Cancer Center, taking the reins of clinical, research and strategic operations. His role will focus on strengthening translational research, patient care integration and institutional partnerships to advance the center's mission — you know, the usual: cure more cancer, argue less in committee meetings.
Related Stories
Small study reports 100% one‑year survival after lung transplant / 21 hrs
High‑dose targeted radiation shows promise for huge bile duct tumors / 3 months
Introducing ISCO 2026 chairs and program highlights / 2 months
Two high‑dose radiotherapy sessions safely treat localized prostate cancer / 7 wks
ESMO issues new metastatic colorectal cancer clinical guideline / 2 months
Florian Lordick elected ESMO president for 2029–2030 term / 4 wks
Bowelbabe Fund reaches £20M and announces vaccine initiative / 3 months
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Pharmaceuticals, FDA, Reproductive Health, Animal Health and look for the RSS link.
StackHealth Time Machine